Applied Genetic Technologies Corporation Gains 23.98%
Tue, Dec 24, 2019 at 05:30 PM
Applied Genetic Technologies Corporation (AGTC:NASDAQ) soared at $4.86, a gain of 24%. On Mon 23 Dec 19, AGTC:NASDAQ hit a New 2-Week High of $3.92. The stock got featured on our News Catalysts scanner on Tue 03 Dec 19 at 12:06 PM in the 'ACQUISITION' category. From Tue 03 Dec 19, the stock recorded 50.00% Up Days and 46.67% Green Days
About Applied Genetic Technologies Corporation (AGTC:NASDAQ)
Applied Genetic Technologies Corp is a clinical-stage biotechnology company focused on gene therapy through a nontoxic adeno-associated virus. The company also offers products such as promoters, expression cassettes, and capsids for gene therapy.
Top 10 Gainers:
- Microbot Medical Inc. (MBOT:NASDAQ), 61.03%
- Proteostasis Therapeutics, Inc. (PTI:NASDAQ), 51.01%
- CLPS Incorporation (CLPS:NASDAQ), 46.12%
- Lineage Cell Therapeutics, Inc. (LCTX:NYSEMKT), 34.52%
- TMSR Holding Company Limited (TMSR:NASDAQ), 33.33%
- Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ), 30.7%
- Soleno Therapeutics, Inc. (SLNO:NASDAQ), 28.57%
- Cassava Sciences, Inc. (SAVA:NASDAQ), 26.74%
- Hi-Crush Inc. (HCR:NYSE), 26.25%
- Applied Genetic Technologies Corporation (AGTC:NASDAQ), 23.98%